---
title: "AllTrials"
chunk: 2/2
source: "https://en.wikipedia.org/wiki/AllTrials"
category: "reference"
tags: "science, encyclopedia"
date_saved: "2026-05-05T04:07:33.346861+00:00"
instance: "kb-cron"
---

== Supporters ==
The campaign is an initiative of Sense about Science, Centre for Evidence Based Medicine, The Dartmouth Institute for Health Policy and Clinical Practice, James Lind Alliance, Cochrane Collaboration, BMJ Group, PLOS, and Bad Science. The petition statement of AllTrials has been signed by organizations including Wellcome Trust, British Library, Medical Research Council (UK), British Heart Foundation, Institute for Quality and Efficiency in Health Care, National Institute for Health and Care Excellence, BioMed Central, National Physicians Alliance, Royal Society of Medicine, Health Research Authority, American Medical Student Association, GlaxoSmithKline, and others.
As of May 2017, The AllTrials petition has been signed by 90,282 people and 721 organisations. In October 2016, AllTrials published a road map detailing steps that various types of organisations can take to get more trials registered and more results reported.
85 investors with >€3.5 trillion (£2.45trn; $3.83trn) of investments have supported AllTrials (as of July 2015), with Peter van der Werf of RobecoSAM saying: "We deem this to be a financially material factor and encourage all companies to gain credibility regarding their approach to clinical trial transparency by signing up to the AllTrials principles.". The Laura and John Arnold Foundation provided early and ongoing financial support.
The original policy of the Coalition for Epidemic Preparedness Innovations required that funded parties pre-register any trials in a clinical trials registry, publish results within a year of study completion (except with compelling reason and permission of CEPI), publish results in open-access articles, and have mechanisms for securely sharing underlying data and results, including negative results, in a way that preserves trial volunteer privacy. In May 2018 the CEPI proposed changing the policy to remove these provisions. The policy was changed by the CEPI in December 2018.

== Opponents ==
The European Federation of Pharmaceutical Industries and Associations and Pharmaceutical Research and Manufacturers of America have expressed interest in lobbying against the campaign. Campaign supporters criticized Hoffmann-La Roche's plans to be more open but not to the extent requested by AllTrials.

== See also ==
Clinical data repository
Conflicts of interest in academic publishing
Monitoring in clinical trials
Metascience
Privacy for research participants
Evidence-based medicine
Clinical trials publication
Censoring (clinical trials)

== References ==

== External links ==
Official website
Where's the rest of the data iceberg?, a video presentation by Ben Goldacre at TEDMED